• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杜普伊特伦挛缩症中的明胶酶A活性

Gelatinase A activity in Dupuytren's disease.

作者信息

Augoff Katarzyna, Ratajczak Katarzyna, Gosk Jerzy, Tabola Renata, Rutowski Roman

机构信息

Department of Gastrointestinal and General Surgery, Wroclaw Medical University, Wroclaw, Poland.

出版信息

J Hand Surg Am. 2006 Dec;31(10):1635-9. doi: 10.1016/j.jhsa.2006.08.007.

DOI:10.1016/j.jhsa.2006.08.007
PMID:17145384
Abstract

PURPOSE

Dupuytren's contracture is a fibroproliferative disorder of the hand characterized by an abnormal myofibroblast and fibroblast proliferation and extracellular matrix deposition leading to retraction and deformation of the palm. Recent studies have shown that molecules of extracellular matrix may coordinate morphogenesis, cell differentiation, and most importantly, fibrogenesis in tissue. Gelatinase A (MMP-2) is a member of the matrix metalloproteinase family of proteolytic enzymes that contribute to remodeling the extracellular matrix by degrading its components. The aim of this study was to determine the level of MMP-2 activation in the palmar fascia of patients with Dupuytren's contracture with reference to the clinical stages of disease progression and recurrence of the contracture after surgery.

METHODS

The level of relative MMP-2 activation, expressed by the active to latent MMP-2 ratio, was investigated with use of zymography and computerized densitometry in 16 normal and 71 pathologic tissues characterizing different clinical stages of the disease progression.

RESULTS

We found that the level of MMP-2 activation was significantly elevated in the palmar fascias with Dupuytren's contracture compared with normal tissues. We did not find statistically significant differences between groups with different stages of the disease progression. We also did not find a relation between a high level of MMP-2 activation and the recurrence in the area of surgically treated Dupuytren's contracture.

CONCLUSIONS

The differences in MMP-2 activation between contractured and normal fascia suggest a participation of this enzyme in the promotion of Dupuytren's disease. We did not find a relationship, however, between the level of MMP-2 activation and the secondary contracture.

摘要

目的

杜普伊特伦挛缩症是一种手部纤维增生性疾病,其特征是异常的肌成纤维细胞和成纤维细胞增殖以及细胞外基质沉积,导致手掌回缩和变形。最近的研究表明,细胞外基质分子可能协调组织中的形态发生、细胞分化,最重要的是纤维生成。明胶酶A(基质金属蛋白酶-2,MMP-2)是蛋白水解酶基质金属蛋白酶家族的成员,通过降解细胞外基质成分来促进其重塑。本研究的目的是参照疾病进展的临床阶段和手术后挛缩的复发情况,确定杜普伊特伦挛缩症患者掌腱膜中MMP-2的激活水平。

方法

采用酶谱法和计算机密度测定法,对16份正常组织和71份代表疾病进展不同临床阶段的病理组织进行研究,以活性与潜伏性MMP-2比值表示相对MMP-2激活水平。

结果

我们发现,与正常组织相比,杜普伊特伦挛缩症患者掌腱膜中的MMP-2激活水平显著升高。我们未发现疾病进展不同阶段的组间存在统计学显著差异。我们也未发现MMP-2激活水平高与手术治疗的杜普伊特伦挛缩症区域复发之间存在关联。

结论

挛缩的和正常的掌腱膜之间MMP-2激活的差异表明该酶参与了杜普伊特伦病的进展。然而,我们未发现MMP-2激活水平与继发性挛缩之间存在关联。

相似文献

1
Gelatinase A activity in Dupuytren's disease.杜普伊特伦挛缩症中的明胶酶A活性
J Hand Surg Am. 2006 Dec;31(10):1635-9. doi: 10.1016/j.jhsa.2006.08.007.
2
Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.基质金属蛋白酶及其抑制剂在杜普伊特伦氏挛缩症患者的 cords 和 nodules 中的表达。
Arch Orthop Trauma Surg. 2009 Nov;129(11):1453-9. doi: 10.1007/s00402-008-0726-3. Epub 2008 Aug 30.
3
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.掌腱膜挛缩症患者血清和组织中的基质金属蛋白酶及金属蛋白酶组织抑制剂
Plast Reconstr Surg. 2003 Oct;112(5):1279-86. doi: 10.1097/01.PRS.0000081462.40448.49.
4
Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.杜普伊特伦挛缩症中细胞外基质蛋白聚糖谱的改变会影响掌腱膜。
J Biochem. 2005 Apr;137(4):463-76. doi: 10.1093/jb/mvi054.
5
Dupuytren's palmar contracture in women.女性掌腱膜挛缩症
Isr Med Assoc J. 2008 Jun;10(6):445-7.
6
Expression of MMP-2, TIMP-2, TGF-β1, and decorin in Dupuytren's contracture.MMP-2、TIMP-2、TGF-β1 和 decorin 在掌腱膜挛缩症中的表达。
Connect Tissue Res. 2012;53(6):469-77. doi: 10.3109/03008207.2012.686542. Epub 2012 Jul 24.
7
Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.杜普伊特伦挛缩症成纤维细胞中骨形态发生蛋白的表达
J Hand Surg Am. 2004 Sep;29(5):809-14. doi: 10.1016/j.jhsa.2004.02.008.
8
Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts.基质金属蛋白酶抑制可减少杜普伊特伦挛缩症成纤维细胞的收缩。
J Hand Surg Am. 2008 Nov;33(9):1608-16. doi: 10.1016/j.jhsa.2008.06.013.
9
Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.掌腱膜挛缩症中的表皮生长因子受体(EGF-R)
J Hand Surg Br. 2005 Dec;30(6):570-3. doi: 10.1016/j.jhsb.2005.06.008. Epub 2005 Aug 2.
10
Dermatan sulfate remodeling associated with advanced Dupuytren's contracture.与晚期掌腱膜挛缩相关的硫酸皮肤素重塑
Acta Biochim Pol. 2007;54(4):821-30. Epub 2007 Dec 9.

引用本文的文献

1
Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.关于分子因素和成纤维细胞在掌腱膜挛缩症发病机制中作用的最新进展。
J Cell Commun Signal. 2016 Dec;10(4):315-330. doi: 10.1007/s12079-016-0331-0. Epub 2016 Jun 7.
2
Scientific understanding and clinical management of Dupuytren disease.Dupuytren 病的科学认识和临床管理。
Nat Rev Rheumatol. 2010 Dec;6(12):715-26. doi: 10.1038/nrrheum.2010.180. Epub 2010 Nov 9.
3
Applications of statistical tests in hand surgery.统计检验在手部外科手术中的应用。
J Hand Surg Am. 2009 Dec;34(10):1872-81. doi: 10.1016/j.jhsa.2009.08.001.
4
The fascia of the limbs and back--a review.四肢及背部的筋膜——综述
J Anat. 2009 Jan;214(1):1-18. doi: 10.1111/j.1469-7580.2008.01011.x.